Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer

Name: Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer
License: Public Domain

Centre Hospitalier Universitaire Dijon

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metastatic non-small cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 162469
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.